Jack Horgan-Jones on Business
After all the hype, Irish biopharma’s golden child Malin Corp has turned out to be a bit of a brat
Exactly what is going on at Malin Corp? The publicly-quoted biopharma investor was launched amid great fanfare in 2015, when it raised €330 million in its initial public offering. Among the key investors at the time was the taxpayer, who put in around €50 million through the state’s Irish Strategic Investment Fund (Isif).
At the time, John Given, the then-chairman of the company, said that its goal was to create “value for shareholders by...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures